Castillo, Patricia Andrea
(2019)
Disruption of Intestinal Th17 Signaling & the Microbiome Exacerbates Extra-Intestinal Pathologies.
Doctoral Dissertation, University of Pittsburgh.
(Unpublished)
Abstract
IL-17 signaling to the intestinal epithelium is a critical regulator of the intestinal microbiome. There is a growing body of research linking alterations in both Th17 cells and the intestinal microbiome to extra-intestinal pathologies including hepatitis and neuroinflammation. For example, many patients with autoimmune, fulminant, and viral hepatitis exhibit increased systemic IL-17, and Il17ra-\- mice are protected in concanavalin A (Con A)-induced hepatitis, a murine model of immune-mediated hepatitis. In Multiple Sclerosis (MS), elevated IL-17 was found in CNS lesions, and disrupted Th17 differentiation in mice ameliorates disease in the experimental autoimmune encephalomyelitis (EAE) mouse model of MS. In addition, many patients with hepatitis and MS display an altered intestinal microbiome, and germ-free mice as well antibiotic-treated mice have decreased disease in Con A hepatitis and EAE. Despite these data, few studies have investigated how the relationship between enteric Th17 cells and the microbiome influences extra-intestinal pathologies.
Based on these reported links, we hypothesized that intestinal IL-17R signaling plays a critical role in mitigating hepatic and neuroinflammation. To test this, we generated intestinal epithelial specific IL-17RA knockout mice (Il17rafl/fl x villin cre+ mice). Because enteric Th17 signaling regulates the commensal microbiota, these mice exhibited an altered intestinal microbiome along with a subsequent expansion of intestinal Th17 cells. We then tested these mice in the Con A hepatitis model and EAE neuroinflammation model.
Our results showed that perturbation of intestinal IL-17RA signaling was sufficient to exacerbate both liver and neuroinflammation in a microbiome-dependent manner. Abrogation of intestinal IL-17RA disrupted the intestinal microbiota and promoted translocation of bacterial products to the liver. Together, this induced IL-18 production and subsequent lymphocyte activation and cell death to worsen hepatitis. In EAE, intestinal IL-17RA deficiency induced intestinal dysbiosis and increased intestinal Il17 and Csf2 and systemic responses in both cytokines. Preliminary data suggested a potential increase of inflammatory monocyte infiltration into the CNS, together exacerbating disease. These dissertation studies elucidate the differential role of enteric Th17 cells and the microbiome in extra-intestinal pathologies and more broadly in mucosal immunology. Moreover, it provides insight into novel therapeutic strategies that target the gut-liver and gut-brain axes.
Share
Citation/Export: |
|
Social Networking: |
|
Details
Item Type: |
University of Pittsburgh ETD
|
Status: |
Unpublished |
Creators/Authors: |
|
ETD Committee: |
|
Date: |
13 September 2019 |
Date Type: |
Publication |
Defense Date: |
14 August 2019 |
Approval Date: |
13 September 2019 |
Submission Date: |
20 August 2019 |
Access Restriction: |
1 year -- Restrict access to University of Pittsburgh for a period of 1 year. |
Number of Pages: |
182 |
Institution: |
University of Pittsburgh |
Schools and Programs: |
School of Medicine > Microbiology and Immunology |
Degree: |
PhD - Doctor of Philosophy |
Thesis Type: |
Doctoral Dissertation |
Refereed: |
Yes |
Uncontrolled Keywords: |
Th17
Microbiome
Hepatitis
Neuroinflammation |
Date Deposited: |
13 Sep 2019 15:12 |
Last Modified: |
13 Sep 2020 05:15 |
URI: |
http://d-scholarship.pitt.edu/id/eprint/37394 |
Metrics
Monthly Views for the past 3 years
Plum Analytics
Actions (login required)
|
View Item |